Ceribell (CBLL) Current Deferred Revenue (2023 - 2026)
Ceribell (CBLL) posted Current Deferred Revenue of $88000.0 for Q1 2026, down 12.87% on a QoQ basis from $101000.0 in Q4 2025, and down 58.88% year-over-year from $214000.0 in Q1 2025.
Ceribell (CBLL) Current Deferred Revenue (2023 - 2026) Analysis & Trends
Ceribell's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $88000.0 for Q1 2026.
- Quarterly Current Deferred Revenue fell 58.88% year-over-year to $88000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88000.0 (down 58.88% YoY) and the FY2025 annual result came in at $101000.0, up 4.12% from the prior year.
- Current Deferred Revenue was $88000.0 for Q1 2026 at Ceribell, down from $101000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $358000.0 in Q1 2024 and bottomed at $88000.0 in Q1 2026.
- A 4-year average of $199727.3 and a median of $214000.0 in 2025 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue slumped 61.2% — and 2025, when it gained 4.12%.
- Ceribell's Current Deferred Revenue stood at $250000.0 in 2023, then slumped by 61.2% to $97000.0 in 2024, then advanced by 4.12% to $101000.0 in 2025, then retreated by 12.87% to $88000.0 in 2026.
- Business Quant data shows CBLL's Current Deferred Revenue at $88000.0 in Q1 2026, $101000.0 in Q4 2025, and $139000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 223,000.00 |
| Mar 31, 2025 | 214,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | 349,000.00 |
| Mar 31, 2024 | 358,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | 240,000.00 |